Artificial Intelligence (AI) In Drug Discovery Market (By Type: Preclinical and Clinical Testing, Molecule Screening, Target Identification, De Novo Drug Design and Drug Optimization; By Application: Neurology, Infectious Disease, Oncology, Others; By Drug Type: Small Molecules, Large Molecules; By Offering: Software, Services; By Technology; By End User) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. End User Procurement Analysis
4.3.2. Sales and Distribution Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Artificial Intelligence (AI) In Drug Discovery Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Artificial Intelligence (AI) In Drug Discovery Market, by Type, 2024-2033
8.1.1. Preclinical and Clinical Testing
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Molecule Screening
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Target Identification
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. De Novo Drug Design and Drug Optimization
8.1.4.1. Market Revenue and Forecast (2021-2033)
9.1. Artificial Intelligence (AI) In Drug Discovery Market, by Application, 2024-2033
9.1.1. Neurology
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Infectious Disease
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Oncology
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2021-2033)
10.1. Artificial Intelligence (AI) In Drug Discovery Market, by Drug Type, 2024-2033
10.1.1. Small Molecules
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Large Molecules
10.1.2.1. Market Revenue and Forecast (2021-2033)
11.1. Artificial Intelligence (AI) In Drug Discovery Market, by Offering, 2024-2033
11.1.1. Software
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Services
11.1.2.1. Market Revenue and Forecast (2021-2033)
12.1. Artificial Intelligence (AI) In Drug Discovery Market, by Technology, 2024-2033
12.1.1. Machine Learning
12.1.1.1. Market Revenue and Forecast (2021-2033)
12.1.2. Other Technologies
12.1.2.1. Market Revenue and Forecast (2021-2033)
13.1. Artificial Intelligence (AI) In Drug Discovery Market, by End User, 2024-2033
13.1.1. Pharmaceutical & Biotechnology Companies
13.1.1.1. Market Revenue and Forecast (2021-2033)
13.1.2. Contract Research Organizations
13.1.2.1. Market Revenue and Forecast (2021-2033)
13.1.3. Academics & Research
13.1.3.1. Market Revenue and Forecast (2021-2033)
13.1.4. Others
13.1.4.1. Market Revenue and Forecast (2021-2033)
14.1. North America
14.1.1. Market Revenue and Forecast, by Type (2021-2033)
14.1.2. Market Revenue and Forecast, by Application (2021-2033)
14.1.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.1.4. Market Revenue and Forecast, by Offering (2021-2033)
14.1.5. Market Revenue and Forecast, by Technology (2021-2033)
14.1.6. Market Revenue and Forecast, by End User (2021-2033)
14.1.7. U.S.
14.1.7.1. Market Revenue and Forecast, by Type (2021-2033)
14.1.7.2. Market Revenue and Forecast, by Application (2021-2033)
14.1.7.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.1.7.4. Market Revenue and Forecast, by Offering (2021-2033)
14.1.8. Market Revenue and Forecast, by Technology (2021-2033)
14.1.8.1. Market Revenue and Forecast, by End User (2021-2033)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Type (2021-2033)
14.1.9.2. Market Revenue and Forecast, by Application (2021-2033)
14.1.9.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.1.9.4. Market Revenue and Forecast, by Offering (2021-2033)
14.1.10. Market Revenue and Forecast, by Technology (2021-2033)
14.1.11. Market Revenue and Forecast, by End User (2021-2033)
14.1.11.1.
14.2. Europe
14.2.1. Market Revenue and Forecast, by Type (2021-2033)
14.2.2. Market Revenue and Forecast, by Application (2021-2033)
14.2.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.2.4. Market Revenue and Forecast, by Offering (2021-2033)
14.2.5. Market Revenue and Forecast, by Technology (2021-2033)
14.2.6. Market Revenue and Forecast, by End User (2021-2033)
14.2.7.
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Type (2021-2033)
14.2.8.2. Market Revenue and Forecast, by Application (2021-2033)
14.2.8.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.2.9. Market Revenue and Forecast, by Offering (2021-2033)
14.2.10. Market Revenue and Forecast, by Technology (2021-2033)
14.2.10.1. Market Revenue and Forecast, by End User (2021-2033)
14.2.11. Germany
14.2.11.1. Market Revenue and Forecast, by Type (2021-2033)
14.2.11.2. Market Revenue and Forecast, by Application (2021-2033)
14.2.11.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.2.12. Market Revenue and Forecast, by Offering (2021-2033)
14.2.13. Market Revenue and Forecast, by Technology (2021-2033)
14.2.14. Market Revenue and Forecast, by End User (2021-2033)
14.2.14.1.
14.2.15. France
14.2.15.1. Market Revenue and Forecast, by Type (2021-2033)
14.2.15.2. Market Revenue and Forecast, by Application (2021-2033)
14.2.15.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.2.15.4. Market Revenue and Forecast, by Offering (2021-2033)
14.2.16. Market Revenue and Forecast, by Technology (2021-2033)
14.2.16.1. Market Revenue and Forecast, by End User (2021-2033)
14.2.17. Rest of Europe
14.2.17.1. Market Revenue and Forecast, by Type (2021-2033)
14.2.17.2. Market Revenue and Forecast, by Application (2021-2033)
14.2.17.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.2.17.4. Market Revenue and Forecast, by Offering (2021-2033)
14.2.18. Market Revenue and Forecast, by Technology (2021-2033)
14.2.18.1. Market Revenue and Forecast, by End User (2021-2033)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Type (2021-2033)
14.3.2. Market Revenue and Forecast, by Application (2021-2033)
14.3.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.3.4. Market Revenue and Forecast, by Offering (2021-2033)
14.3.5. Market Revenue and Forecast, by Technology (2021-2033)
14.3.6. Market Revenue and Forecast, by End User (2021-2033)
14.3.7. India
14.3.7.1. Market Revenue and Forecast, by Type (2021-2033)
14.3.7.2. Market Revenue and Forecast, by Application (2021-2033)
14.3.7.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.3.7.4. Market Revenue and Forecast, by Offering (2021-2033)
14.3.8. Market Revenue and Forecast, by Technology (2021-2033)
14.3.9. Market Revenue and Forecast, by End User (2021-2033)
14.3.10. China
14.3.10.1. Market Revenue and Forecast, by Type (2021-2033)
14.3.10.2. Market Revenue and Forecast, by Application (2021-2033)
14.3.10.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.3.10.4. Market Revenue and Forecast, by Offering (2021-2033)
14.3.11. Market Revenue and Forecast, by Technology (2021-2033)
14.3.11.1. Market Revenue and Forecast, by End User (2021-2033)
14.3.12. Japan
14.3.12.1. Market Revenue and Forecast, by Type (2021-2033)
14.3.12.2. Market Revenue and Forecast, by Application (2021-2033)
14.3.12.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.3.12.4. Market Revenue and Forecast, by Offering (2021-2033)
14.3.12.5. Market Revenue and Forecast, by Technology (2021-2033)
14.3.12.6. Market Revenue and Forecast, by End User (2021-2033)
14.3.13. Rest of APAC
14.3.13.1. Market Revenue and Forecast, by Type (2021-2033)
14.3.13.2. Market Revenue and Forecast, by Application (2021-2033)
14.3.13.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.3.13.4. Market Revenue and Forecast, by Offering (2021-2033)
14.3.13.5. Market Revenue and Forecast, by Technology (2021-2033)
14.3.13.6. Market Revenue and Forecast, by End User (2021-2033)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Type (2021-2033)
14.4.2. Market Revenue and Forecast, by Application (2021-2033)
14.4.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.4.4. Market Revenue and Forecast, by Offering (2021-2033)
14.4.5. Market Revenue and Forecast, by Technology (2021-2033)
14.4.6. Market Revenue and Forecast, by End User (2021-2033)
14.4.7. GCC
14.4.7.1. Market Revenue and Forecast, by Type (2021-2033)
14.4.7.2. Market Revenue and Forecast, by Application (2021-2033)
14.4.7.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.4.7.4. Market Revenue and Forecast, by Offering (2021-2033)
14.4.8. Market Revenue and Forecast, by Technology (2021-2033)
14.4.9. Market Revenue and Forecast, by End User (2021-2033)
14.4.10. North Africa
14.4.10.1. Market Revenue and Forecast, by Type (2021-2033)
14.4.10.2. Market Revenue and Forecast, by Application (2021-2033)
14.4.10.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.4.10.4. Market Revenue and Forecast, by Offering (2021-2033)
14.4.11. Market Revenue and Forecast, by Technology (2021-2033)
14.4.12. Market Revenue and Forecast, by End User (2021-2033)
14.4.13. South Africa
14.4.13.1. Market Revenue and Forecast, by Type (2021-2033)
14.4.13.2. Market Revenue and Forecast, by Application (2021-2033)
14.4.13.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.4.13.4. Market Revenue and Forecast, by Offering (2021-2033)
14.4.13.5. Market Revenue and Forecast, by Technology (2021-2033)
14.4.13.6. Market Revenue and Forecast, by End User (2021-2033)
14.4.14. Rest of MEA
14.4.14.1. Market Revenue and Forecast, by Type (2021-2033)
14.4.14.2. Market Revenue and Forecast, by Application (2021-2033)
14.4.14.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.4.14.4. Market Revenue and Forecast, by Offering (2021-2033)
14.4.14.5. Market Revenue and Forecast, by Technology (2021-2033)
14.4.14.6. Market Revenue and Forecast, by End User (2021-2033)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Type (2021-2033)
14.5.2. Market Revenue and Forecast, by Application (2021-2033)
14.5.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.5.4. Market Revenue and Forecast, by Offering (2021-2033)
14.5.5. Market Revenue and Forecast, by Technology (2021-2033)
14.5.6. Market Revenue and Forecast, by End User (2021-2033)
14.5.7. Brazil
14.5.7.1. Market Revenue and Forecast, by Type (2021-2033)
14.5.7.2. Market Revenue and Forecast, by Application (2021-2033)
14.5.7.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.5.7.4. Market Revenue and Forecast, by Offering (2021-2033)
14.5.8. Market Revenue and Forecast, by Technology (2021-2033)
14.5.8.1. Market Revenue and Forecast, by End User (2021-2033)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Type (2021-2033)
14.5.9.2. Market Revenue and Forecast, by Application (2021-2033)
14.5.9.3. Market Revenue and Forecast, by Drug Type (2021-2033)
14.5.9.4. Market Revenue and Forecast, by Offering (2021-2033)
14.5.9.5. Market Revenue and Forecast, by Technology (2021-2033)
14.5.9.6. Market Revenue and Forecast, by End User (2021-2033)
15.1. NVIDIA CORPORATION
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Microsoft Corporation
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. INSILICO MEDICINE INC.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Schrödinger
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5. EXSCIENTIA
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Cloud Pharmaceuticals
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. TOMWISE, INC
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
17.1. About Us
17.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client